Jim Cramer: Novocure, Veru, and Regeneron - Buy, Sell, or Hold
  • 3 years ago
Novocure's stock rockets. Jim Cramer gives his take. Plus, a look at Veru and Regeneron, 'buy, hold, sell' style.
Recommended